Skip to site content

COVID-19

2021

HHS Pause in Distribution of MABs & Omicron Variant (Dec 2021) [PDF - 295 KB]

EUA for oral antiviral molnupiravir (Dec 2021) [PDF - 277 KB]

EUA for oral nirmatrelvir-ritonavir [Paxlovid®] (Dec 2021) [PDF - 275 KB]

Drug Safety Alert_Janssen COVID-19 Vaccine EUA Update: Increased risk of TTS (Dec 2021) [PDF - 201 KB]

Pfizer-BioNTech COVID-19 Vaccine (expanded EUA) Booster Dose in 16 and 17 Year Olds (Dec 2021) [PDF - 327 KB]

Tixagevimab and Cilgavimab (Evusheld) EUA (Dec 2021) [PDF - 286 KB]

Bamlanivimab-Etesevimab EUA expanded for COVID Treatment and Post-Exposure Prophylaxis in Pediatrics and Newborns (Dec 2021) [PDF - 412 KB]

FDA Expands Eligibility for COVID-19 Vaccine Boosters (Nov 2021) [PDF - 298 KB]

Pfizer-BioNTech COVID-19 Vaccine expanded for children aged 5-11 years (Nov 2021) [PDF - 289 KB]

Moderna and Janssen Vaccine Boosters & Mix and Match (Oct 2021) [PDF - 656 KB]

Pfizer-BioNTech Vaccine Booster (Sept 2021) [PDF - 689 KB]

EUA Update: Resumption of Bamlanivumab-Etesevimab Use (Sept 2021) [PDF - 197 KB]

Third Dose for Immune Compromised (August 2021) [PDF - 706 KB]

Updates to REGEN-COV EUA (August 2021) [PDF - 756 KB]

FDA Surveillance of 4 Adverse Events of Interest & Pfizer/BioNTech Vaccine (July 2021) [PDF - 126 KB]

Guillain-Barré Syndrome & Janssen/Johnson and Johnson COVID-19 Vaccine (July 2021) [PDF - 230 KB]

Tocilizumab EUA (July 2021) [PDF - 738 KB]

Casirivimab and Imdevimab (REGEN-COV) EUA Update (June 2021) [PDF - 728 KB]

Bamlanivumab-Etesevimab Distribution Paused (June 2021) [PDF - 294 KB]

FDA warning: mRNA COVID-19 vaccines & myo- and pericarditis (June 2021) [PDF - 146 KB]

Sotrovimab EUA (June 2021) [PDF - 757 KB]

05-2021 COVID Vaccine and myo_pericarditis (June 2021) [PDF - 106 KB]

Suspected COVID-19 P.1 Variant Resistance to bamlanivimab/etesevimab (May 2021) [PDF - 159 KB]

Amended EUA: Pfizer-BioNTech COVID-19 Vaccine_Use in Adolescents Aged 12-15 years (May 2021) [PDF - 244 KB]

COVID-19 Clinical Update - NPTC Meeting (April 2021) [PDF - 199 KB]

Drug Safety Alert_Johnson & Johnson/Janssen Vaccine Update (April 2021) [PDF - 105 KB]

Revocation of Bamlanivimab monotherapy EUA (April 2021) [PDF - 526 KB]

Johnson & Johnson/Janssen COVID-19 Vaccine (April 2021) [PDF - 143 KB]

Janssen COVID-19 Vaccine EUA (Mar 2021) [PDF - 543 KB]

Bamlanivimab and Etesevimab EUA (Feb 2021) [PDF - 748 KB]

NPTC COVID-19 Emerging Treatments & Vaccine Update (Jan 2021) [PDF - 188 KB]

COVID-19 Vaccine Safety Alert: Anaphylaxis (Jan 2021) [PDF - 356 KB]